|
Market Closed -
Other stock markets
|
After hours 01:48:33 am | |||
| 209.03 USD | +4.96% |
|
213.44 | +2.11% |
| 12:24am | FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug | RE |
| 05:10pm | Wedbush Raises Price Target on Biogen to $201 From $196, Keeps Neutral Rating | MT |
| Market Cap | 2.94TCr 2.58TCr 2.39TCr 2.2TCr 4.16TCr 2,81400Cr 4.24TCr 28TCr 11TCr 1,38200Cr 11TCr 11TCr 4,77300Cr | P/E 2026 * |
32.3x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49TCr 3.06TCr 2.84TCr 2.61TCr 4.94TCr 3,34100Cr 5.03TCr 34TCr 13TCr 1,64100Cr 13TCr 13TCr 5,66700Cr | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +4.96% | ||
| 1 week | +0.27% | ||
| Current month | -3.25% | ||
| 1 month | +5.23% | ||
| 3 months | +18.52% | ||
| 6 months | +17.23% | ||
| Current year | +18.77% |
| 1 week | 194.37 |  | 212 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.12 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% | ||
| 09/06 | Fiscal year | Director | 6,245 | 0.0042% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +0.27% | +57.04% | -24.80% | 2.94TCr | |
| -0.22% | +2.04% | +16.21% | -8.03% | 6.76TCr | |
| -0.63% | -7.39% | +36.54% | +199.82% | 5.16TCr | |
| +0.36% | +40.00% | +40.00% | +40.00% | 4.3TCr | |
| -1.26% | -0.39% | -49.63% | -53.84% | 4.09TCr | |
| -1.85% | -18.08% | +103.86% | -47.07% | 2.71TCr | |
| -2.12% | -1.20% | +63.23% | +84.42% | 2.33TCr | |
| -0.67% | +1.48% | +10.61% | +188.35% | 1.99TCr | |
| -2.12% | -3.92% | +56.13% | +130.60% | 1.69TCr | |
| -3.27% | +6.86% | +74.21% | +379.95% | 1.68TCr | |
| Average | -0.77% | -1.83% | +40.82% | +88.94% | 3.37TCr | |
| Weighted average by Cap. | -0.49% | -2.34% | +32.81% | +64.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 882.28Cr 817.16Cr 751.88Cr 1.42TCr 96TCr 1.45TCr 9.74TCr 3.82TCr 47TCr 3.78TCr 3.69TCr 1,63300Cr | 1.04TCr 912.05Cr 844.73Cr 777.24Cr 1.47TCr 1LCr 1.5TCr 10TCr 3.95TCr 49TCr 3.9TCr 3.82TCr 1,68800Cr |
| Net income | 141.59Cr 124.19Cr 115.02Cr 105.83Cr 200.18Cr 14TCr 204.07Cr 1.37TCr 537.67Cr 6.66TCr 531.68Cr 520.06Cr 23TCr | 197.74Cr 173.44Cr 160.63Cr 147.8Cr 279.56Cr 19TCr 285Cr 1.91TCr 750.89Cr 9.29TCr 742.53Cr 726.29Cr 32TCr |
| Net Debt | 550.87Cr 483.17Cr 447.51Cr 411.76Cr 778.82Cr 53TCr 793.97Cr 5.33TCr 2.09TCr 26TCr 2.07TCr 2.02TCr 89TCr | 338.49Cr 296.89Cr 274.98Cr 253.01Cr 478.55Cr 32TCr 487.86Cr 3.28TCr 1.29TCr 16TCr 1.27TCr 1.24TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | $209.03 | +4.96% | 22,54,133 |
| 10/26/10 | $199.15 | +0.12% | 11,33,120 |
| 09/26/09 | $198.91 | -0.72% | 16,57,327 |
| 08/26/08 | $200.36 | -2.60% | 19,47,888 |
| 07/26/07 | $205.70 | -1.32% | 11,56,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
